Ken Kuang: When Fluid Dynamics Meets Life-Saving Surgery
Ken Kuang, President of Torrey Hills Technologies, LLC, Partner of StockFan App, Advisor at Unpress AI, shared a post on LinkedIn:
“When Fluid Dynamics Meets Life-Saving Surgery.
Traditional medicine tells us that stubborn blood clots—the ‘white clots’ rich in fibrin—are some of the hardest obstacles to clear during a stroke.
Current suction methods often fail because these clots are too tough to aspirate, leaving surgeons with few options.
Enter the Stanford ‘Milli-spinner.’
Researchers at Stanford Medicine and Engineering have developed a tiny, high-speed rotating device that doesn’t just ‘suck’ or ‘grab’—it re-engineers the clot in real-time.
The Engineering Breakthrough:
- Mechanical Shrinking: By spinning at up to 40,000 RPM, the device creates a localized ‘rubbing’ effect.
- The 5 percent Factor: It compresses a clot to just 5 percent of its original volume, squeezing out red blood cells and condensing the fibrin into a tiny, dense bead.
- Precision Aspiration: Once condensed, the ‘shrunk’ clot is easily vacuumed out without breaking into dangerous fragments.
In trials, this ‘cotton ball’ approach jumped the success rate for tough clots from 11 percent to 90 percent on the first pass.
It’s a masterclass in how mechanical engineering and fluid dynamics can solve biological bottlenecks.
This tech is now heading toward human trials and could soon be the gold standard for treating strokes, pulmonary embolisms, and even heart attacks.
What do you think?
Is the future of surgery less about ‘cutting’ and more about high-speed mechanical manipulation at the micro-scale?”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Aug 20, 2026, 08:13Felice Gragnano: LDL-C Treatment Is Not Enough – Reaching the Target Matters
-
Aug 20, 2026, 06:15Muhammad Umair Mushtaq: Outcomes of Matched Sibling Versus Haploidentical Transplantation
-
Aug 20, 2026, 06:03Access to Bleeding Disorder Treatment Shouldn’t Depend on Where You Live – WFH
-
Aug 20, 2026, 04:42Chris Zahner: Why Healthy People Can Have Abnormal Lab Results
-
Aug 20, 2026, 03:57Reza Shojaei: What the First U.S. Freeze-Dried Plasma Approval Means
-
Aug 20, 2026, 01:23Jessica Erley: Understanding Patient Experience Beyond the Clinical Encounter
-
Aug 20, 2026, 01:19Dries De Wolf: Innovative Gene Therapy for Hemophilia B
-
Aug 19, 2026, 19:09Gregory Lip: PFO Closure in Younger Patients With Cryptogenic Stroke
-
Aug 19, 2026, 18:51Filippo Crea: AF and Alzheimer’s Disease – Does the Anticoagulant Choice Matter for the Brain?